India Digital Therapeutics/DTx Market (2026-2031)
The India Digital Therapeutics/DTx Market was valued at $465.1 Million in 2026 and projected to reach to $1727 Million by 2031, representing a compound annual growth rate of 30.0%. India's Digital Therapeutics market is poised for transformative growth, driven by a convergence of demographic, technological, and regulatory factors.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India Digital Therapeutics/DTx Market Trends and Insights
- This represents a compound annual growth rate of 30.0%, significantly outpacing global trends.
- India's large population, increasing smartphone penetration, and growing healthcare digitalization initiatives are driving adoption of DTx solutions across chronic disease management, mental health, and preventive care segments. The Indian DTx market is benefiting from rising healthcare costs, a substantial patient base seeking accessible treatment options, and government support for digital health infrastructure.
- India's regulatory environment is evolving to accommodate DTx innovations, with the Central Drugs Standard Control Organization (CDSCO) establishing frameworks for digital therapeutic approval.
- By 2031, India is expected to become a significant hub for DTx development and deployment, driven by local startups, multinational investments, and partnerships between technology companies and healthcare providers. India's DTx market growth is underpinned by increasing prevalence of lifestyle diseases, limited access to specialist care in rural areas, and the rising adoption of telemedicine platforms.
- The market's trajectory reflects India's broader digital health transformation and its potential to serve as both a consumer market and innovation center for digital therapeutics in the Asia Pacific region..
Key Market Statistics
- CAGR (2026-2031) 30.0% CAGR
- Market Size, 2026 ~USD 465.1 Million
- Forecast, 2031 ~USD 1727 Million
- Country India
India Digital Therapeutics/DTx Market Overview
Explosive Growth Trajectory :
India's DTx market is projected to grow from $465.1 million in 2026 to $1,727.0 million by 2031, representing a 30% CAGR—significantly outpacing the global average of 26.4%.
Digital Health Infrastructure Expansion :
Government initiatives like National Digital Health Mission (NDHM) and Ayushman Bharat are accelerating digital health adoption, creating a favorable ecosystem for DTx solutions across urban and rural India.
Smartphone Penetration Advantage :
With over 750 million smartphone users and increasing internet accessibility, India presents an unparalleled opportunity for mobile-first DTx applications targeting chronic disease management and preventive care.
Cost-Effective Healthcare Solution :
DTx solutions address India's healthcare affordability challenges by providing accessible, scalable alternatives to traditional treatment, particularly for diabetes, hypertension, and mental health conditions.
India Digital Therapeutics/DTx Market Dynamics
- The country's massive population base, combined with rising smartphone penetration and government-backed digital health initiatives, creates an ideal environment for DTx adoption.
- Healthcare providers and insurers are increasingly recognizing DTx as a cost-effective solution to manage chronic diseases and reduce hospital burden. By 2031, India is expected to emerge as a key DTx hub in Asia-Pacific, with significant investments from both domestic startups and global players.
- Regulatory clarity through frameworks like the Digital Health Ecosystem and growing reimbursement models will further accelerate market penetration.
- The convergence of AI, wearables, and telemedicine with DTx solutions will unlock new use cases, particularly in preventive care and remote patient monitoring across India's diverse healthcare landscape..
Market Ecosystem
DIGITAL THERAPEUTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
AI-enabled virtual care, chronic disease management, remote patient monitoring (RPM), and integrated digital therapeutics platform | Improved patient engagement, reduced hospitalizations, enhanced chronic disease outcomes, and expanded access to virtual care |
 |
AI-powered behavior change platform, digital weight management, nutrition coaching, and personalized lifestyle interventions | Sustainable weight loss, improved metabolic health, higher patient adherence, and reduced risk of chronic diseases |
 |
AI-driven musculoskeletal (MSK) digital therapy, wearable-enabled motion tracking, computer vision, and virtual physical therapy | Faster recovery, reduced pain, lower musculoskeletal treatment costs, and decreased need for surgery or opioid use |
 |
Digital chronic disease prevention and management platform for diabetes, hypertension, obesity, and cardiovascular health using connected devices and personalized coaching | Improved clinical outcomes, better disease control, increased medication adherence, and reduced healthcare expenditures |
 |
AI-powered digital therapeutics platform integrating glucose monitoring, blood pressure monitoring, behavioral health, and personalized coaching | Better disease self-management, improved patient outcomes, enhanced engagement, and lower total cost of care |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Healthcare Analytics
- Machine Learning
- Natural Language Processing (NLP)
- Blood Pressure Monitors
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Oracle Corporation
- PHILIPS HEALTHCARE
- Siemens healthineers
- Zensar Technologies Limited
- EPIC SYSTEMS CORPORATION
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- India's DTx market is projected to grow from $465.1M (2026) to $1,727.0M (2031) at a 30.0% CAGR, outpacing global growth rates.
- India's large population, high disease burden, and smartphone penetration create substantial demand for accessible digital therapeutic solutions.
- Government digital health initiatives and evolving regulatory frameworks are accelerating DTx adoption and investment in India.
- India is positioned to emerge as both a major DTx consumer market and a regional innovation and development hub by 2031.
Digital Therapeutics/DTx Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IMMERSIVE & INTERFACE-BASED THERAPEUTICS (Offering) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 26.4% from 2026 to 2031 |
| Largest Segment | B2B SALES CHANNELS (Sales Channel) |
| Market Size Base Year (Billions) | ~USD 10.96 (2026) |
| Revenue Forecast (Billions) | ~USD 35.37 (2031) |
| Segments Covered | Offering, Product Type, Application, Type, Revenue Model, Sales Channel, End User |
India Digital Therapeutics/DTx Market Report Segmentation
7 segment dimensions are covered across the global market.
By Offering
- Immersive & Interface-Based Therapeutics
- Software/Platforms
- Therapeutic Programs
By Product Type
- Non-Prescription Digital Therapeutics
- Prescription Digital Therapeutics
By Application
- Preventive Applications
- Treatment & Care-Related Applications
By Type
- Cardiovascular Diseases
- Central Nervous System (Cns) Disorders
- Chronic Respiratory Diseases
- Diabetes
- Diagnostic & Rehabilitation Centers
- Hospitals
- Medication Adherence
- Musculoskeletal Disorders
- Nutrition & Lifestyle Management
- Obesity & Weight Management
- Other Healthcare Providers
- Other Preventive Applications
- Other Treatment & Care-Related Applications
- Prediabetes
- Private Payers
- Public Payers
- Rehabilitation & Patient Care
- Sleep Disorders
- Smoking Cessation
- Specialty Clinics
- Substance Use Disorders & Addiction Management
By Revenue Model
- Licensing (Enterprise/SaaS) Models
- Outcome-/Value-Based Models
- Subscription-Based Models
By Sales Channel
- B2B Sales Channels
- B2C Sales Channels
By End User
- Employers
- Healthcare Payers
- Healthcare Providers
- Other End Users
- Patients/Individuals
Target Audience
- DTx Startups & Entrepreneurs : Need India-specific market data to validate business models, secure funding, and develop localized DTx solutions addressing India's unique healthcare challenges and patient demographics.
- Healthcare Providers & Hospital Networks : Require market insights to evaluate DTx adoption opportunities, understand competitive offerings, and make informed decisions on integrating digital therapeutics into clinical workflows.
- Insurance Companies & Payers : Need comprehensive market analysis to assess DTx reimbursement potential, identify cost-saving opportunities, and develop coverage policies aligned with India's evolving digital health ecosystem.
- Pharmaceutical & MedTech Companies : Seek India market intelligence to explore DTx partnerships, identify acquisition targets, and develop complementary digital solutions that enhance traditional drug and device offerings.
- Government & Policy Makers : Require data-driven insights to shape digital health policies, allocate resources effectively, and accelerate DTx integration into national health programs and public healthcare systems.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation ($465.1M in 2026, $1,727M in 2031) and 30% CAGR data specific to India, enabling accurate financial forecasting and investment decision-making for DTx ventures.
- Competitive Landscape Intelligence : Understand India-specific market dynamics, key players, and competitive positioning to identify white-space opportunities and develop targeted go-to-market strategies for DTx products.
- Regulatory & Reimbursement Insights : Access India-specific regulatory frameworks, government health initiatives (NDHM, Ayushman Bharat), and emerging reimbursement models to navigate compliance and accelerate market entry.
- Customer Segmentation & Adoption Drivers : Leverage detailed analysis of India's healthcare providers, insurers, and patient demographics to identify high-potential segments and tailor DTx solutions for maximum market penetration.
- Risk Mitigation & Strategic Planning : Reduce investment risk by understanding India-specific challenges, market barriers, and growth catalysts, enabling informed strategic planning and resource allocation for long-term success.
Frequently asked questions
What is the projected market size of Digital Therapeutics in India by 2031?
India's DTx market is projected to reach $1,727.0 million by 2031, growing from $465.1 million in 2026 at a 30.0% CAGR.
What are the primary drivers of DTx market growth in India?
Key drivers include India's large population, rising prevalence of chronic diseases, increasing smartphone penetration, limited access to specialist care in rural areas, and government support for digital health infrastructure.
How does India's DTx growth rate compare to global trends?
India's 30.0% CAGR significantly exceeds the global DTx market CAGR of 26.4%, positioning India as one of the fastest-growing DTx markets.
What regulatory framework governs Digital Therapeutics in India?
India's Central Drugs Standard Control Organization (CDSCO) is establishing regulatory frameworks for DTx approval, creating a structured pathway for digital therapeutic innovations.
Which therapeutic areas are driving DTx adoption in India?
Chronic disease management, mental health, preventive care, and lifestyle disease management are the primary therapeutic areas driving DTx adoption in India.
RESEARCH METHODOLOGY
This research study involved the extensive use of both primary and secondary sources. It involved the analysis of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.
Secondary Research
This research study extensively utilized secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as white papers, annual reports, and companies' house documents. The secondary research aimed to gather and analyze information for a comprehensive and commercially focused study of the digital therapeutics market, encompassing technical aspects and market dynamics. It also facilitated the identification of key players, market classification, industry trends, geographical markets, and significant market-related developments. Additionally, a database of prominent industry leaders was compiled through secondary research.
Primary Research
In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the digital therapeutics market. Primary sources from the demand side included personnel from healthcare providers, payers, employees, and patients/individuals.
Others include sales managers, marketing managers, and product managers.
Note: Tiers are defined based on a company’s total revenue, as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the digital therapeutics market was determined after data triangulation through the two approaches mentioned below. After the completion of each approach, the weighted average of these approaches was taken based on the level of assumptions used in each approach.
Global Digital Therapeutics Market Size: Top-down Approach and Bottom-up Approach
Data Triangulation
The size of the digital therapeutics market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as given below:
- Revenues for individual companies were gathered from public sources and databases.
- Shares of leading players in the digital therapeutics market were gathered from secondary sources to the extent available. In certain cases, shares of digital therapeutics businesses have been ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, selling price, and geographic reach & strength.
- Individual shares or revenue estimates were validated through interviews with experts.
- The total revenue in the digital therapeutics market was determined by extrapolating the market share data of major companies.
Market Definition
The digital therapeutics market comprises evidence-based, clinically validated software solutions designed to prevent, manage, or treat medical conditions through therapeutic interventions delivered via digital technologies. These solutions are delivered through mobile applications, web-based platforms, connected devices, and immersive technologies, and may be prescribed by healthcare professionals or accessed directly by consumers. By leveraging data analytics, artificial intelligence (AI), and personalized behavioral interventions, digital therapeutics improve clinical outcomes, enhance patient engagement, and support the prevention and management of acute and chronic diseases.
Key Stakeholders
- Digital therapeutics developers and platform providers
- Pharmaceutical and biotechnology companies
- Healthcare providers (hospitals, specialty clinics, rehabilitation centers, and primary care centers)
- Health insurance companies (public and private payers)
- Employers and corporate wellness providers
- Medical device and wearable technology companies
- Academic medical centers, universities, and research institutions
- Regulatory agencies and health technology assessment (HTA) bodies
- Government and public health organizations
- Telehealth and digital health platform providers
- Electronic health record (EHR) and healthcare IT solution providers
- Investors, venture capital firms, and private equity firms
- Patients and patient advocacy organizations
- Business research and consulting service providers
Report Objectives
- To define, describe, and forecast the digital therapeutics market based on offering, product type, application, revenue model, sales channel, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall digital therapeutics market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and analyze their market shares and core competencies
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, and collaborations in the overall digital therapeutics market
- To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific digital therapeutics market into Taiwan, New Zealand, Thailand, Singapore, Malaysia, and other countries
- Further breakdown of the Rest of Europe digital therapeutics market into Russia, Austria, Finland, Sweden, Turkey, Norway, Poland, Portugal, Romania, Denmark, and other countries
Get the Full Digital Therapeutics/DTx Market Report
Full forecast, segment splits, and company analysis for all Digital Therapeutics/DTx Market.
- US Digital Therapeutics/DTx Market
- Canada Digital Therapeutics/DTx Market
- Germany Digital Therapeutics/DTx Market
- France Digital Therapeutics/DTx Market
- UK Digital Therapeutics/DTx Market
- Italy Digital Therapeutics/DTx Market
- Spain Digital Therapeutics/DTx Market
- China Digital Therapeutics/DTx Market
- Japan Digital Therapeutics/DTx Market
- Australia Digital Therapeutics/DTx Market
- South Korea Digital Therapeutics/DTx Market
- Brazil Digital Therapeutics/DTx Market
- Mexico Digital Therapeutics/DTx Market
- Saudi Arabia Digital Therapeutics/DTx Market
- UAE Digital Therapeutics/DTx Market
- South Africa Digital Therapeutics/DTx Market
- Rest Of Europe Digital Therapeutics/DTx Market
- Rest Of Asia Pacific Digital Therapeutics/DTx Market
- Rest Of Latin America Digital Therapeutics/DTx Market
- GCC Countries Digital Therapeutics/DTx Market
- Rest Of GCC Countries Digital Therapeutics/DTx Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
